Improvement of Cancer-Targeting Therapy, Using Nanocarriers for Intractable Solid Tumors by Inhibition of TGF-beta Signaling

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0611660104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Inhibition of Breast Cancer Cell Motility With a Non-Cyclooxygenase Inhibitory Derivative of Sulindac by Suppressing TGFβ/miR-21 Signaling

Oncotarget
Oncology
2016English

Rejuvenation by Inhibiting TGF-β1/pSmad Signaling

Oncotarget
Oncology
2015English

Role of TGF-β Signaling in Uterine Carcinosarcoma

Oncotarget
Oncology
2015English

TGF-Beta Antibody for Prostate Cancer: Role of ERK

2011English

Onivyde for the Therapy of Multiple Solid Tumors

OncoTargets and Therapy
OncologyPharmacology
2016English

Targeting Therapy of Human Solid Tumors With Adriamycin-Entrapped Liposomes Bearing Monoclonal Antibodies.

Drug Delivery System
Pharmaceutical Science
1993English

Predicting Bone Metastatic Potential of Prostate Cancer via Computational Modeling of TGF-Beta Signaling

2008English

Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors

Clinical Cancer Research
Cancer ResearchOncology
2013English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy